Our Blog

Botanix Pharmaceuticals (ASX:BOT) cap raising

02 Aug 2019 – Botanix Pharmaceuticals (ASX:BOT) Executive Director Matthew Callahan talks about the company’s cap raising, promising proof points in the performance of cannabinoids in treating skin disease and strategic goals for the next 6 months.


Source: Finance News Network

Share this post